Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Parasomnias, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, nervous system disorder, psychiatric disorder, skin disorder, sleep disorder, sleep-wake disorder	Recruiting	Phase 4	2026-04-27		NCT05042258

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Northwestern University	381
Regeneron Pharmaceuticals	238

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Lurie Children's Hospital/Northwestern University	Chicago	United States	2